Clinical trial
Heterozygous Individuals for AGXT and Kidney Stones
NCT04430426 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heterozygous Individuals for AGXT and Kidney Stones
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2027
- Completion date
- August 1, 2032
- Enrollment
- 4 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney stone, urolithiasis, calcium oxalate